Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen Jen Yeh

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Angiogenesis|June 9, 2026
Characterizing pancreatic cancer-associated fibroblast heterogeneity in vascular microphysiological systemsCharles W Blackledge, Sarah Gullion, Ian McCabe, et al.
Journal of the American Statistical Association|September 22, 2021
High-Dimensional Precision Medicine From Patient-Derived XenograftsNaim U Rashid, Daniel J Luckett, Jingxiang Chen, et al.
Surgery|December 8, 2007
Utilization of total thyroidectomy for papillary thyroid cancer in the United StatesKarl Y Bilimoria, David J Bentrem, John G Linn, et al.
Carcinogenesis|January 26, 2011
The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cellsDapeng Xu, Stephen A Allsop, Sam M Witherspoon, et al.
Nucleic Acids Research|August 18, 2016
Selective single cell isolation for genomics using microraft arraysJoshua D Welch, Lindsay A Williams, Matthew DiSalvo, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2018
Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancerJames D Byrne, Mohammad R N Jajja, Adrian T O'Neill, et al.
Molecular Cancer Therapeutics|April 18, 2009
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancerJen Jen Yeh, Elizabeth D Routh, Tara Rubinas, et al.
Journal of Surgical Oncology|December 23, 2024
New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular SubtypeHannah E Trembath, Michelle E LaBella, Joseph F Kearney, et al.
Plos One|March 14, 2012
Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinomaNina V Chaika, Fang Yu, Vinee Purohit, et al.
JCO Precision Oncology|December 4, 2018
Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic AdenocarcinomaRobert J Torphy, Zhen Wang, Aisha True-Yasaki, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Angiogenesis|June 9, 2026
Characterizing pancreatic cancer-associated fibroblast heterogeneity in vascular microphysiological systemsCharles W Blackledge, Sarah Gullion, Ian McCabe, et al.
Journal of the American Statistical Association|September 22, 2021
High-Dimensional Precision Medicine From Patient-Derived XenograftsNaim U Rashid, Daniel J Luckett, Jingxiang Chen, et al.
Surgery|December 8, 2007
Utilization of total thyroidectomy for papillary thyroid cancer in the United StatesKarl Y Bilimoria, David J Bentrem, John G Linn, et al.
Carcinogenesis|January 26, 2011
The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cellsDapeng Xu, Stephen A Allsop, Sam M Witherspoon, et al.
Nucleic Acids Research|August 18, 2016
Selective single cell isolation for genomics using microraft arraysJoshua D Welch, Lindsay A Williams, Matthew DiSalvo, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2018
Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancerJames D Byrne, Mohammad R N Jajja, Adrian T O'Neill, et al.
Molecular Cancer Therapeutics|April 18, 2009
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancerJen Jen Yeh, Elizabeth D Routh, Tara Rubinas, et al.
Journal of Surgical Oncology|December 23, 2024
New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular SubtypeHannah E Trembath, Michelle E LaBella, Joseph F Kearney, et al.
Plos One|March 14, 2012
Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinomaNina V Chaika, Fang Yu, Vinee Purohit, et al.
JCO Precision Oncology|December 4, 2018
Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic AdenocarcinomaRobert J Torphy, Zhen Wang, Aisha True-Yasaki, et al.
Pageof 12